PFG Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,306
Closed -$317K 603
2023
Q2
$317K Sell
9,306
-1,639
-15% -$51.5K 0.02% 506
2023
Q1
$329K Buy
10,945
+18
+0.2% +$558 0.03% 467
2022
Q4
$308K Sell
10,927
-798
-7% -$25.3K 0.03% 446
2022
Q3
$385K Sell
11,725
-2,711
-19% -$99.5K 0.04% 366
2022
Q2
$455K Sell
14,436
-25,184
-64% -$881K 0.05% 260
2022
Q1
$1.82M Sell
39,620
-10,909
-22% -$520K 0.18% 123
2021
Q4
$3.09M Sell
50,529
-10,500
-17% -$726K 0.3% 85
2021
Q3
$4.56M Buy
61,029
+4,003
+7% +$336K 0.5% 37
2021
Q2
$5.28M Buy
57,026
+12,216
+27% +$1.04M 0.6% 29
2021
Q1
$3.98M Buy
44,810
+14,144
+46% +$1.4M 0.51% 42
2020
Q4
$2.86M Buy
30,666
+15,582
+103% +$1.24M 0.48% 53
2020
Q3
$1.06M Buy
15,084
+1,374
+10% +$80.5K 0.2% 131
2020
Q2
$764K Buy
13,710
+1,716
+14% +$73.6K 0.17% 151
2020
Q1
$463K Buy
+11,994
New +$401K 0.12% 183

Other funds holding ARKG

PFG Advisors's ARKG Position: Q3 2023 in Review

PFG Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2023, closing a stake of 9,306 shares — an estimated $317K sold.

PFG Advisors first reported a position in ARKG in Q1 2020 and held it in 14 quarters. The position peaked at $5.28M in Q2 2021. 287 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

  • PFG Advisors reported no remaining ARK Genomic Revolution ETF position as of Q3 2023 after selling out during the quarter.
  • PFG Advisors sold 9,306 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $317K.
  • PFG Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2020 and held it in 14 quarters.
  • PFG Advisors's ARK Genomic Revolution ETF position peaked at $5.28M in Q2 2021.
  • 287 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on PFG Advisors's 13F filing for Q3 2023, filed 13 Oct 2023.